Allergic Reactions to Metamizole: Immediate and Delayed Responses

Fecha de publicación:

Autores de IIS La Fe

  • Elena García Martín

    Autor

  • Miguel Ángel Miranda Alonso

    Autor

  • Irene Mayorga Ruiz

    Autor

  • Lucia Doñate Bertolin

    Autor

Participantes ajenos a IIS La Fe

  • Blanca-López N
  • Pérez-Sánchez N
  • Agúndez JA
  • Torres MJ
  • Cornejo-García JA
  • Perkins JR
  • Canto G
  • Blanca M

Grupos

Abstract

Background: Pyrazolones are the most common causes of selective nonsteroidal anti-inflammatory drug (NSAID) hypersensitivity. We studied a large group of patients with immediate and delayed selective responses to metamizole. Methods: Patients with suspicion of hypersensitivity to metamizole were evaluated. We verified acetylsalicylic acid tolerance and classified patients as immediate or delayed responders if they showed symptoms less or more than 24 h after metamizole administration. Skin tests were performed and if negative, a basophil activation test (BAT) was performed on immediate responders. If it was negative, we performed a drug provocation test (DPT) with metamizole. Results: A total of 137 patients were included: 132 reacted within 24 h (single NSAID-induced urticaria/angioedema/anaphylaxis; SNIUAA) and 5 after 24 h (single NSAID-induced delayed hypersensitivity reaction; SNIDHR). Most SNIUAA patients developed anaphylaxis (60.60%); for SNIDHR, maculopapular exanthema was the most frequent entity (60%). Skin testing was positive in 62.04% of all cases and BAT in 28% of the SNIUAA patients with negative skin tests. In 5.1% of the cases, DPT with metamizole was needed to establish the diagnosis. In 22.62% of the cases, diagnosis was established by consistent and unequivocal history of repeated allergic episodes in spite of a negative skin test and BAT. Conclusions: SNIUAA to metamizole is the most frequent type of selective NSAID hypersensitivity, with anaphylaxis being the most common clinical entity. It may occur within 1 h after drug intake. SNIDHR occurs in a very low percentage of cases. The low sensitivity of diagnostic tests may be due to incomplete characterization of the chemical structures of metamizole and its metabolites. (C) 2016 S. Karger AG, Basel

Datos de la publicación

ISSN/ISSNe:
1018-2438, 1423-0097

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY  KARGER

Tipo:
Article
Páginas:
223-230
PubMed:
27224978
Factor de Impacto:
1,055 SCImago
Cuartil:
Q1 SCImago

Citas Recibidas en Web of Science: 30

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Basophil activation test; Drug provocation test; Metamizole; Selective hypersensitivity; Skin test

Proyectos y Estudios Clínicos

DEVELOPMENT OF A MECHANISTICALLY-BASED CELL ASSAY FOR ANTICIPATING THE PHOTOGENOTOXIC POTENTIAL OF BIOACTIVE CHEMICALS AND THEIR METABOLITES

CP11/00154 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2012

PLATAFORMA DE UNIDADES DE INVESTIGACION CLINICA Y ENSAYOS CLINICOS

Investigador Principal: JOSÉ VICENTE CASTELL RIPOLL

PT13/0002/0032 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2014

ESTUDIO DE DURABILIDAD DEL TRIFECTA.

Investigador Principal: JOSÉ ANASTASIO MONTERO ARGUDO

CS-10-012-EU-TV . 2011

Cita

Compartir